Taking advantage of certain immunogenic neoepitopes derived from mutations present in CMT64,11 we then assessed the tumor-specific T cell response in splenocytes by interferon-gamma (IFN-γ)-Enzyme-Linked ImmunoSpot (ELISpot). The gene discussed is IFNG; the disease is neoplasm.